SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000078003-21-000107
Filing Date
2021-11-12
Accepted
2021-11-12 06:06:57
Documents
94
Period of Report
2021-10-03

Document Format Files

Seq Description Document Type Size
1 10-Q pfe-20211003.htm   iXBRL 10-Q 4342344
2 EX-31.1 pfe-exh311x1003202110q.htm EX-31.1 9178
3 EX-31.2 pfe-exh312x1003202110q.htm EX-31.2 9197
4 EX-32.1 pfe-exh321x1003202110q.htm EX-32.1 4621
5 EX-32.2 pfe-exh322x1003202110q.htm EX-32.2 4625
  Complete submission text file 0000078003-21-000107.txt   18215360

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT pfe-20211003.xsd EX-101.SCH 94083
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT pfe-20211003_cal.xml EX-101.CAL 173361
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT pfe-20211003_def.xml EX-101.DEF 442347
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT pfe-20211003_lab.xml EX-101.LAB 987611
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT pfe-20211003_pre.xml EX-101.PRE 658927
11 EXTRACTED XBRL INSTANCE DOCUMENT pfe-20211003_htm.xml XML 4850522
Mailing Address 235 E 42ND ST NEW YORK NY 10017
Business Address 235 E 42ND ST NEW YORK NY 10017 2125732323
PFIZER INC (Filer) CIK: 0000078003 (see all company filings)

IRS No.: 135315170 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-03619 | Film No.: 211398951
SIC: 2834 Pharmaceutical Preparations